AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

MariMed Inc.

$0.07 -$0.02 (-16.78%)
OTC · 15 Sep 2026 17:51 UTC
Previous Close
$0.08
Day Range
$0.07$0.07
Year Range
$0.06$0.18
Market Cap
29.91M
AVG Volume
492.86K
Trailing/Forward PE
-1.99/-
PEG ratio
0.08
Dividend Yield
-
Next Earnings Date
2026-11-04
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MRMD Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q2163.82M
26 Q1161.51M
25 Q4159.98M
25 Q3157.33M
25 Q2157.16M
25 Q1157.99M
24 Q4157.96M
24 Q3157.86M
24 Q2156.07M
24 Q1152.15M
Net Income (USD) · TTM
-20M-15M-10M-5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MRMD Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2-14.95M
26 Q1-12.63M
25 Q4-14.3M
25 Q3-17.87M
25 Q2-15.94M
25 Q1-16.32M
24 Q4-12.15M
24 Q3-14.12M
24 Q2-17.36M
24 Q1-16.67M
Operating Income (USD) · TTM
-5M05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MRMD Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2-1.53M
26 Q1-923K
25 Q4-2.07M
25 Q3484K
25 Q2225K
25 Q1390K
24 Q43.26M
24 Q37.13M
24 Q29.08M
24 Q111.32M
EBITDA (USD) · TTM
05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MRMD EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q210.09M
26 Q110.77M
25 Q49.44M
25 Q312.3M
25 Q211.92M
25 Q111.78M
24 Q414.19M
24 Q37M
24 Q28.7M
24 Q110.59M
Cash Flows (USD) · TTM
-10M-5M05M10M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MRMD Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q28.26M
26 Q16.08M
25 Q46.53M
25 Q31.61M
25 Q22.21M
25 Q1326K
24 Q4-1.12M
24 Q3-1.75M
24 Q2-2.8M
24 Q1-5.12M
EPS (USD) · TTM
-0.06-0.04-0.02024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MRMD EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q2-0.04
26 Q1-0.03
25 Q4-0.04
25 Q3-0.05
25 Q2-0.04
25 Q1-0.04
24 Q4-0.03
24 Q3-0.04
24 Q2-0.05
24 Q1-0.04
Expenses (USD) · TTM
-25M025M50M75M100MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MRMD Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q224.86M
26 Q131.9M
25 Q431.29M
25 Q339.41M
25 Q229.95M
25 Q135.84M
24 Q446.43M
24 Q357.51M
24 Q278.56M
24 Q175.72M
Shares Outstanding (USD) · TTM
-4M-2M02M4MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MRMD Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-1.44M
26 Q1-1.64M
25 Q4-1.86M
25 Q3-1.76M
25 Q2-2.65M
25 Q1-2.34M
24 Q4-2.04M
24 Q3603K
24 Q21.58M
24 Q11.53M
Employee Count
02505007501K2016201720182019202020212022202320242025
MRMD Employee Count by quarter
PeriodEmployee Count
2025808
2024715
2023643
2022592
2021260
2020181
201981
201828
201712
20164
PE Ratio
050100150200med 27.15Feb 22May 22Sep 22Dec 22Apr 23Jul 23Nov 23
MRMD PE Ratio by quarter
PeriodPE Ratio
Nov 2318.73
Oct 2319.81
Oct 2324.64
Oct 2323.65
Oct 2324.17
Sep 2326.97
Sep 2328.48
Sep 2331.58
Sep 2329.66
Sep 2326.25
Aug 2318.1
Aug 2317.52
Aug 2317.95
Aug 2322.03
Jul 2315.11
Jul 2315.72
Jul 2316.04
Jul 2316.31
Jun 2316.31
Jun 2315.72
Jun 2315.52
Jun 2316.44
Jun 2316.31
May 2316.31
May 2318.3
May 2319.5
May 2311.85
Apr 239.64
Apr 239.74
Apr 239.58
Apr 239.58
Mar 239.89
Mar 239.58
Mar 2310.36
Mar 2311.29
Mar 2310.96
Feb 2379.31
Feb 2381.52
Feb 2372.98
Feb 2375.05
Jan 2371.08
Jan 2368.15
Jan 2372.41
Jan 2369.01
Dec 2261.45
Dec 2265.56
Dec 2267.29
Dec 2280.23
Dec 2289.72
Nov 2291.44
Nov 2289.72
Nov 2292.3
Nov 22129.57
Oct 22129.14
Oct 22134.62
Oct 22138.36
Oct 22162.05
Sep 22108.02
Sep 22107.2
Sep 22132.13
Sep 22143.35
Sep 22147.09
Aug 22154.32
Aug 22152.07
Aug 22163.79
Aug 2236.87
Jul 2238.19
Jul 2240.03
Jul 2236.87
Jul 2230.55
Jul 2225.29
Jun 2224.23
Jun 2227.34
Jun 2230.45
Jun 2232.13
May 2232.5
May 2232.66
May 2232.66
May 2226.48
Apr 2228.73
Apr 2231.87
Apr 2232.54
Apr 2232.99
Apr 2233.21
Mar 2233.48
Mar 2231.19
Mar 2213.68
Mar 2213.29
Feb 2214.15
Feb 2214.39
Feb 2216.24
Feb 2215.87
Jan 2213.1
Jan 2214.21
Jan 2215.28
Jan 2216.24
Dec 2115.96
Dec 2113.93
Dec 2113.47
Dec 2114.12
Free Cash Flow Yield
-10%0%10%20%30%40%med 3.95%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
MRMD Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2626.83%
Sep 2626.22%
Sep 2625.82%
Aug 2625.04%
Aug 2624.08%
Aug 2630.38%
Aug 2622.57%
Jul 2624.27%
Jul 2623.25%
Jul 2623.24%
Jul 2622.49%
Jul 2622.58%
Jun 2621.38%
Jun 2621.84%
Jun 2622.16%
Jun 2621.07%
May 2619.6%
May 2620.39%
May 2622.96%
May 2619.43%
May 2618.46%
Apr 2620.9%
Apr 2624.29%
Apr 2623.63%
Apr 2624.83%
Mar 2621.79%
Mar 2621.59%
Mar 2619.92%
Mar 264.89%
Feb 264.84%
Feb 265.12%
Feb 265.13%
Feb 264.69%
Jan 264.73%
Jan 264.52%
Jan 264.39%
Jan 264.51%
Jan 264.56%
Dec 254.19%
Dec 253.71%
Dec 253.83%
Dec 254.98%
Nov 254.58%
Nov 254.85%
Nov 254.87%
Nov 254.03%
Oct 254.65%
Oct 253.59%
Oct 253.71%
Oct 253.44%
Oct 253.66%
Sep 253.95%
Sep 253.95%
Sep 254.13%
Sep 253.65%
Aug 253.62%
Aug 255.04%
Aug 255.15%
Aug 255.81%
Aug 250.87%
Jul 250.73%
Jul 250.91%
Jul 250.82%
Jul 250.99%
Jun 251.22%
Jun 251.22%
Jun 251.18%
Jun 251.19%
May 251.01%
May 251.15%
May 251.07%
May 250.9%
May 25-2.73%
Apr 25-2.74%
Apr 25-2.97%
Apr 25-3.8%
Apr 25-3.42%
Mar 25-3.06%
Mar 25-3.04%
Mar 25-2.88%
Mar 25-2.71%
Feb 25-4.05%
Feb 25-3.41%
Feb 25-3.07%
Feb 25-3.51%
Jan 25-4.09%
Jan 25-3.8%
Jan 25-4%
Jan 25-4.14%
Jan 25-3.57%
Dec 24-3.85%
Dec 24-3.89%
Dec 24-3.52%
Dec 24-3.18%
Nov 24-3.14%
Nov 24-3.08%
Nov 24-2.85%
Nov 24-2.81%
Nov 24-4.57%
Oct 24-4.47%
Price to Sales
0.10.20.30.40.5med 0.23Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
MRMD Price to Sales by quarter
PeriodPrice to Sales
Sep 260.19
Sep 260.19
Sep 260.2
Aug 260.2
Aug 260.21
Aug 260.17
Aug 260.17
Jul 260.16
Jul 260.16
Jul 260.16
Jul 260.17
Jul 260.17
Jun 260.18
Jun 260.17
Jun 260.17
Jun 260.18
May 260.19
May 260.18
May 260.16
May 260.21
May 260.22
Apr 260.2
Apr 260.17
Apr 260.17
Apr 260.16
Mar 260.19
Mar 260.19
Mar 260.2
Mar 260.21
Feb 260.21
Feb 260.2
Feb 260.2
Feb 260.22
Jan 260.22
Jan 260.23
Jan 260.23
Jan 260.23
Jan 260.22
Dec 250.24
Dec 250.28
Dec 250.27
Dec 250.21
Nov 250.22
Nov 250.21
Nov 250.21
Nov 250.25
Oct 250.3
Oct 250.39
Oct 250.38
Oct 250.41
Oct 250.38
Sep 250.36
Sep 250.36
Sep 250.34
Sep 250.39
Aug 250.39
Aug 250.28
Aug 250.27
Aug 250.24
Aug 250.24
Jul 250.28
Jul 250.23
Jul 250.25
Jul 250.21
Jun 250.17
Jun 250.17
Jun 250.18
Jun 250.17
May 250.2
May 250.18
May 250.19
May 250.23
May 250.26
Apr 250.26
Apr 250.24
Apr 250.19
Apr 250.21
Mar 250.23
Mar 250.23
Mar 250.25
Mar 250.26
Feb 250.27
Feb 250.33
Feb 250.36
Feb 250.32
Jan 250.27
Jan 250.29
Jan 250.28
Jan 250.27
Jan 250.31
Dec 240.29
Dec 240.28
Dec 240.32
Dec 240.35
Nov 240.35
Nov 240.36
Nov 240.39
Nov 240.39
Nov 240.39
Oct 240.4
EV/EBITDA
510152025med 11.1Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
MRMD EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2611.2
Sep 2611.28
Sep 2611.32
Aug 2611.42
Aug 2611.55
Aug 2610.85
Aug 2610.23
Jul 2610.06
Jul 2610.16
Jul 2610.16
Jul 2610.24
Jul 2610.23
Jun 2610.37
Jun 2610.32
Jun 2610.28
Jun 2610.41
May 2610.61
May 2610.5
May 2610.19
May 2613.22
May 2613.4
Apr 2612.97
Apr 2612.51
Apr 2612.59
Apr 2612.44
Mar 2612.83
Mar 2612.86
Mar 2613.13
Mar 2610.92
Feb 2610.94
Feb 2610.8
Feb 2610.79
Feb 2611.03
Jan 2611.01
Jan 2611.14
Jan 2611.22
Jan 2611.14
Jan 2611.11
Dec 2511.36
Dec 2511.77
Dec 2511.66
Dec 2510.87
Nov 2511.1
Nov 2510.94
Nov 2510.93
Nov 2511.49
Oct 2510.79
Oct 2511.97
Oct 2511.8
Oct 2512.2
Oct 2511.87
Sep 2511.49
Sep 2511.49
Sep 2511.29
Sep 2511.89
Aug 2511.93
Aug 2510.48
Aug 2510.4
Aug 259.99
Aug 2510
Jul 2510.6
Jul 259.88
Jul 2510.21
Jul 259.63
Jun 259.11
Jun 259.11
Jun 259.19
Jun 259.17
May 259.56
May 259.24
May 259.43
May 259.92
May 258.62
Apr 258.61
Apr 258.39
Apr 257.81
Apr 258.04
Mar 258.31
Mar 258.33
Mar 258.47
Mar 258.64
Feb 2517.57
Feb 2518.73
Feb 2519.54
Feb 2518.53
Jan 2517.51
Jan 2517.98
Jan 2517.64
Jan 2517.44
Jan 2518.39
Dec 2417.89
Dec 2417.81
Dec 2418.5
Dec 2419.26
Nov 2419.36
Nov 2419.52
Nov 2420.16
Nov 2420.28
Nov 2418.1
Oct 2418.26
Price/Operating Cashflow
010203040med 5.5Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
MRMD Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 263.32
Sep 263.4
Sep 263.45
Aug 263.56
Aug 263.7
Aug 262.93
Aug 263.66
Jul 263.41
Jul 263.55
Jul 263.56
Jul 263.68
Jul 263.66
Jun 263.87
Jun 263.78
Jun 263.73
Jun 263.92
May 264.22
May 264.06
May 263.6
May 264.37
May 264.6
Apr 264.06
Apr 263.49
Apr 263.59
Apr 263.42
Mar 263.89
Mar 263.93
Mar 264.26
Mar 268.56
Feb 268.64
Feb 268.17
Feb 268.15
Feb 268.92
Jan 268.85
Jan 269.26
Jan 269.54
Jan 269.28
Jan 269.17
Dec 259.98
Dec 2511.28
Dec 2510.91
Dec 258.4
Nov 259.13
Nov 258.62
Nov 258.59
Nov 2510.39
Oct 2524.02
Oct 2531.09
Oct 2530.07
Oct 2532.49
Oct 2530.52
Sep 2528.26
Sep 2528.26
Sep 2527.05
Sep 2530.62
Aug 2530.86
Aug 2522.13
Aug 2521.66
Aug 2519.2
Aug 257.67
Jul 259.12
Jul 257.36
Jul 258.17
Jul 256.76
Jun 255.49
Jun 255.5
Jun 255.7
Jun 255.65
May 256.6
May 255.82
May 256.27
May 257.47
May 256.06
Apr 256.04
Apr 255.58
Apr 254.36
Apr 254.84
Mar 255.41
Mar 255.45
Mar 255.76
Mar 256.11
Feb 254.15
Feb 254.93
Feb 255.47
Feb 254.79
Jan 254.1
Jan 254.42
Jan 254.2
Jan 254.06
Jan 254.7
Dec 244.36
Dec 244.31
Dec 244.77
Dec 245.28
Nov 245.34
Nov 245.45
Nov 245.88
Nov 245.97
Nov 243.49
Oct 243.57
Price to Book
0.40.60.811.2med 0.65Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
MRMD Price to Book by quarter
PeriodPrice to Book
Sep 260.71
Sep 260.73
Sep 260.74
Aug 260.76
Aug 260.79
Aug 260.63
Aug 260.58
Jul 260.54
Jul 260.56
Jul 260.56
Jul 260.58
Jul 260.58
Jun 260.61
Jun 260.6
Jun 260.59
Jun 260.62
May 260.67
May 260.64
May 260.57
May 260.67
May 260.71
Apr 260.62
Apr 260.54
Apr 260.55
Apr 260.53
Mar 260.6
Mar 260.6
Mar 260.66
Mar 260.61
Feb 260.61
Feb 260.58
Feb 260.58
Feb 260.63
Jan 260.63
Jan 260.66
Jan 260.68
Jan 260.66
Jan 260.65
Dec 250.71
Dec 250.8
Dec 250.77
Dec 250.6
Nov 250.65
Nov 250.61
Nov 250.61
Nov 250.74
Oct 250.81
Oct 251.05
Oct 251.02
Oct 251.1
Oct 251.03
Sep 250.96
Sep 250.96
Sep 250.92
Sep 251.04
Aug 251.05
Aug 250.75
Aug 250.73
Aug 250.65
Aug 250.63
Jul 250.75
Jul 250.61
Jul 250.67
Jul 250.56
Jun 250.45
Jun 250.45
Jun 250.47
Jun 250.46
May 250.54
May 250.48
May 250.52
May 250.61
May 250.69
Apr 250.68
Apr 250.63
Apr 250.49
Apr 250.55
Mar 250.61
Mar 250.62
Mar 250.65
Mar 250.69
Feb 250.64
Feb 250.76
Feb 250.84
Feb 250.74
Jan 250.63
Jan 250.68
Jan 250.65
Jan 250.62
Jan 250.72
Dec 240.67
Dec 240.66
Dec 240.73
Dec 240.81
Nov 240.82
Nov 240.84
Nov 240.9
Nov 240.92
Nov 240.89
Oct 240.91
MariMed Inc.
MRMD
Stockpicker

Video analysis: MRMD

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: MRMD

MariMed Inc. (MRMD) Q2 2026 Earnings Call Transcript

seekingalpha.com · 13 Aug 2026

MariMed Inc. (MRMD) Q2 2026 Earnings Call Transcript

MariMed Inc. (MRMD) Q2 2026 Earnings Call Transcript

MariMed Reports Second Quarter 2026 Earnings

globenewswire.com · 12 Aug 2026

MariMed Reports Second Quarter 2026 Earnings

NORWOOD, Mass., Aug. 12, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the second quarter ended June 30, 2026.

MariMed Embraces Pumpkin Season By Unveiling New Products That Bring Seasonal Autumn Flavors to Cannabis Consumers

globenewswire.com · 6 Aug 2026

MariMed Embraces Pumpkin Season By Unveiling New Products That Bring Seasonal Autumn Flavors to Cannabis Consumers

NORWOOD, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQB:MRMD) is gearing up for a cozy fall with a line of limited-edition product offerings for the season.

MariMed Announces Second Quarter 2026 Earnings Date

globenewswire.com · 15 Jul 2026

MariMed Announces Second Quarter 2026 Earnings Date

NORWOOD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its second quarter 2026 financial results on August 12, 2026 after the markets close.

MariMed Announces Second Quarter 2026 Earnings Date

globenewswire.com · 15 Jul 2026

MariMed Announces Second Quarter 2026 Earnings Date

NORWOOD, Mass. , July 15, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or the "Company") (CSE: MRMD) (OTCQB: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its second quarter 2026 financial results on August 12, 2026 after the markets close.

MariMed's Betty's Eddies™ Expands Core Lineup with New Multi-Vitamin Inspired Betty's Bite-A-Mins

globenewswire.com · 14 Jul 2026

MariMed's Betty's Eddies™ Expands Core Lineup with New Multi-Vitamin Inspired Betty's Bite-A-Mins

NORWOOD, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Betty's Eddies ™, the all-natural cannabis fruit chews handcrafted for specific health and wellness effects, is expanding its core lineup with the introduction of Betty's Bite-A-Mins, a daily wellness chew that combines full-spectrum cannabis, CBD, and essential vitamins in one delicious bite.

MariMed's Nature's Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign

globenewswire.com · 7 Jul 2026

MariMed's Nature's Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign

NORWOOD, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- MariMed's (“MariMed”) (CSE: MRMD) (OTCQB: MRMD) award-winning flower, vape and concentrate brand, Nature's Heritage™ , today announced the launch of ‘The Nose Knows,' an immersive, science-backed consumer education campaign designed to help consumers better understand which cannabis products and strains align best to their preferences.

MariMed Submits DEA Registration Applications For State-Licensed Medical Cannabis Businesses

globenewswire.com · 25 Jun 2026

MariMed Submits DEA Registration Applications For State-Licensed Medical Cannabis Businesses

NORWOOD, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator, today announced the Company has submitted applications with the U.S. Drug Enforcement Agency (“DEA”) to register certain state-licensed medical cannabis operations.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.